BCYC Q3 2022 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-29.8% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$30M-978.9% margin

Net Income

-$28M-932.5% margin

EPS (Diluted)

$-0.96

QoQ Revenue Growth

-30.6%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$8M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$417M

Total Liabilities

$128M

Stockholders' Equity

$289M

Cash & Equivalents

$361M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-29.8%
Gross Profit	$3M	$4M	-29.8%
Operating Income	-$30M	-$14M	-108.2%
Net Income	-$28M	-$15M	-93.1%